BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8129464)

  • 1. Antibodies to intermediate filaments in polymyalgia rheumatica/giant cell arteritis: do they reflect the underlying disease activity rather than the acute phase response?
    Monteagudo I; Corrigall V; Panayi GS; Pountain G; Hazleman BL
    Ann Rheum Dis; 1994 Feb; 53(2):150. PubMed ID: 8129464
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibodies to intermediate filaments in polymyalgia rheumatica and giant cell arteritis: a sequential study.
    Dasgupta B; Duke O; Kyle V; Macfarlane DG; Hazleman BL; Panayi GS
    Ann Rheum Dis; 1987 Oct; 46(10):746-9. PubMed ID: 2446569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Has the time come for biotherapies in giant cell arteritis and polymyalgia rheumatica?
    Devauchelle-Pensec V
    Joint Bone Spine; 2016 Oct; 83(5):471-2. PubMed ID: 27526638
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibodies to cardiolipin and beta 2 glycoprotein I in patients with polymyalgia rheumatica and giant cell arteritis.
    Meyer O; Nicaise P; Moreau S; de Bandt M; Palazzo E; Hayem G; Chazerain P; Labarre C; Kahn MF
    Rev Rhum Engl Ed; 1996 Apr; 63(4):241-7. PubMed ID: 8738442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-neutrophil cytoplasm antibodies in giant cell arteritis and polymyalgia rheumatica.
    Meyer O; De Bandt M; Haim T; Kahn MF
    Ann Med Interne (Paris); 1992; 143(7):476. PubMed ID: 1300870
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum immunoglobulin G4 in giant cell arteritis and polymyalgia rheumatica.
    Burkel M; Arndt F; Schirmer JH; Moosig F; Holle JU
    Clin Exp Rheumatol; 2017; 35 Suppl 103(1):94-97. PubMed ID: 27974093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of polymyalgia rheumatica and giant-cell arteritis with HLA-B8.
    Hazleman B; Goldstone A; Voak D
    Br Med J; 1977 Oct; 2(6093):989-91. PubMed ID: 922399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-neutrophil cytoplasm antibodies in patients with giant cell arteritis and/or polymyalgia rheumatica.
    Berthelot JM; Lamour A; Mottier D; Pennec YL; Dueymes M; Jouquan J; Le Goff P; Youinou P
    Ann Med Interne (Paris); 1992; 143(7):429-32. PubMed ID: 1300861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA antigens in patients with giant cell arteritis and polymyalgia rheumatica.
    Hunder GG; Taswell HF; Pineda AA; Elveback LR
    J Rheumatol; 1977; 4(3):321-3. PubMed ID: 926109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypothyroidism in polymyalgia rheumatica and giant cell arteritis.
    Wiseman P; Stewart K; Rai GS
    BMJ; 1989 Mar; 298(6674):647-8. PubMed ID: 2496792
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prevalence of antiphospholipid antibodies in Horton's disease and in polymyalgia rheumatica].
    Hulin C; Hachulla E; Michon-Pasturel U; Hatron PY; Masy E; Gillot JM; Caron C; Arvieux J; Flipo RM; Devulder B
    Rev Med Interne; 1999 Aug; 20(8):659-63. PubMed ID: 10480168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymyalgia rheumatica and temporal arteritis in blacks--clinical features and HLA typing.
    Sanford RG; Berney SN
    J Rheumatol; 1977; 4(4):435-42. PubMed ID: 604481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Large vessel vasculitis : Giant cell arteritis and Takayasu arteritis].
    Villiger PM
    Z Rheumatol; 2017 Aug; 76(6):509-523. PubMed ID: 28638968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating immune complexes in giant cell arteritis and polymyalgia rheumatica.
    Papaioannou CC; Gupta RC; Hunder GG; McDuffie FC
    Arthritis Rheum; 1980 Sep; 23(9):1021-5. PubMed ID: 7417351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-DR locus antigens in polymyalgia rheumatica and giant cell arteritis.
    Calamia KT; Moore SB; Elveback LR; Hunder GG
    J Rheumatol; 1981; 8(6):993-6. PubMed ID: 6948960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-6 in clinical relapses of polymyalgia rheumatica and giant cell arteritis.
    Caplanne D; Le Parc JM; Alexandre JA
    Ann Rheum Dis; 1996 Jun; 55(6):403-4. PubMed ID: 8694583
    [No Abstract]   [Full Text] [Related]  

  • 17. The relationship of anti-endothelial cell antibodies to anti-phospholipid antibodies in patients with giant cell arteritis and/or polymyalgia rheumatica.
    Le Tonquèze M; Dueymes M; Giovangrandi Y; Beigbeder G; Jouquan J; Pennec YL; Mottier D; Le Goff P; Youinou P
    Autoimmunity; 1995; 20(1):59-66. PubMed ID: 7578862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dysimmune manifestations in Horton's disease and polymyalgia rheumatica].
    De Coninck P; Büschges B; Thouvenin T; Auxenfants E; Bouton Y; Plouvier B
    Presse Med; 1989 Sep; 18(29):1435. PubMed ID: 2529526
    [No Abstract]   [Full Text] [Related]  

  • 19. HLA-DR antigens in polymyalgia rheumatica and giant cell arteritis.
    Gouet D; Alcalay D; Azais I; Alcalay M; Becq-Giraudon B; Sudre Y; Bontoux D
    J Rheumatol; 1985 Jun; 12(3):627-8. PubMed ID: 3862847
    [No Abstract]   [Full Text] [Related]  

  • 20. Behaviour of von Willebrand factor antigen in follow-up of polymyalgia rheumatica/giant cell arteritis.
    Ciompi ML; Marotta G; Puccetti L; Remorini E; Petrini G; Zuccotti M; Vispi M; Baicchi U; Iacconi P
    Scand J Rheumatol; 1988; 17(6):491-5. PubMed ID: 3266032
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.